Trial Information
The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture
Inclusion Criteria:
- Subjects of this pilot study are limited to those female patients who are undergoing
therapeutic or prophylactic mastectomy procedures conducted by the department of
Surgery at HUMC.
Exclusion Criteria:
- From within this population, no exclusion criteria shall be applied based on age,
race, ethnicity, gender, HIV status, or menopause.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Cell line data study
Outcome Time Frame:
one year
Safety Issue:
No
Principal Investigator
Erik F Young, Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Hackensack University Medical Center
Authority:
United States: Institutional Review Board
Study ID:
07.01.041
NCT ID:
NCT00481585
Start Date:
May 2007
Completion Date:
Related Keywords:
- Breast Cancer
- claudin
- electrophysiology
- breast
- screening
- Breast Neoplasms
Name | Location |
Hackensack Univeristy Medical Center |
Hackensack, New Jersey 07601 |